 
    Rubén Fernández-Santiago
Sobre mí
I earned a degree in Biology from the University of Oviedo in 2003 and a PhD in Neuroscience from the University of Tübingen in Germany in 2009 (Director: Prof. Thomas Gasser). I joined the lab of Prof. Eduardo Tolosa at IDIBAPS-Hospital Clínic de Barcelona in 2009 to investigate Parkinson disease (PD). I hold an ISCIII Miguel Servet position as independent PI and as Assoc. Prof. at the University of Barcelona. My research applies multi-disciplinary translational OMICS such as advanced epi-/genomics, transcriptomics, and phospho-proteomics to tackle the molecular mechanisms leading to neurodegeneration and to identify PD progression biomarkers, most especially at early prodromal stages. 
    Publicaciones destacadas
- 
                    SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's DiseaseAutores:Referencia: Movement Disorders 2019.
- 
                    Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson's disease patientsAutores:Referencia: Clinical Epigenetics 2019.
- 
                    MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patientsAutores:Referencia: Neurobiology Of Aging 2018.
- 
                    α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in SpainAutores:Referencia: Movement Disorders 2018.
- 
                    ABSENCE OF LRRK2 MUTATIONS IN A COHORT OF PATIENTS WITH IDIOPATHIC REM SLEEP BEHAVIOR DISORDERAutores:Referencia: Neurology 2016.
- 
                    The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.Autores:Referencia: Annals Of Neurology 2015.
- 
                    MicroRNA Association with Synucleinopathy Conversion in Rapid Eye Movement Behavior DisorderAutores:Referencia: Annals Of Neurology 2015.
Proyectos destacados
- 
                ‘Phospho-proteome analysis of PBMCs in LRRK2 mutation carriers: expansion and validation of findings of the Barcelona LRRK2 Biorepository’ / Parkinson’s Pathway Biomarkers Fall 2020Investigador/a principal: Ruben Fernandez SantiagoCódigo: MJFF-000858Duración: 28/02/2021 - 28/02/2023
- 
                ‘Tackling the epigenetic regulation of a-synuclein in Parkinson disease’ / ISCIII AES-20 Proyectos de Investigación en Salud (FIS)Investigador/a principal: Ruben Fernandez SantiagoCódigo: PI20/00659Duración: 01/01/2021 - 31/12/2023
- 
                'The beginnings of Parkinson Disease: a study of early disease mechanisms in a humanized in-vitro model'Investigador/a principal: Rubén Fernández-SantiagoCódigo: SAF2015-73508-JINDuración: 01/01/2016 - 01/01/2019
- 
                ‘MicroRNAs as biomarkers of the prodromal stage of Parkinson disease’Investigador/a principal: Mario EzquerraCódigo: 11159Duración: 01/01/2016 - 01/01/2018
- 
                ‘Gene-gene interaction analysis of the mTOR pathway in L-DOPA induced dyskinesia’Investigador/a principal: Mario Ezquerra TrabalónCódigo: MJFF_DYSK_2014Duración: 01/01/2014 - 01/01/2016
